resourceId,resourceName,resourceType,observationText,observationType,observationPhase,observationTime,observationTimeUnits,doi
d7008ce3-09ef-4150-a793-69bdde435b66,NCI-H1838,['Cell Line'],"The NCI-H1838 cell line was one of seven cancer cell lines included in the NCI-7 Cell Line Panel, which was found to be suitable for benchmarking laboratory sample preparation methods and as a universal standard proteomic reference.","['Cell line panel', 'Proteomics']",,,,https://www.doi.org/10.1021/acs.jproteome.8b00165
d7008ce3-09ef-4150-a793-69bdde435b66,NCI-H1838,['Cell Line'],"The NCI-H1838 cell line exhibited sensitivity to the PARP inhibitor AZD2281, with an IC50 value less than 5 Î¼M in a 5-day drug treatment assay.",['Drug response'],,,,https://doi.org/10.1158/2159-8290.CD-12-0112
